|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Pharmacy White Paper, published in April 2008 (Pharmacy in England. Building on strengths – delivering the future), set out plans for a greater role for pharmacy in promoting health and supporting patients with long-term conditions. Pharmacist access to care records will be an important factor in the profession’s ability to provide new and extended services to patients. This submission sets out the reasons why pharmacists need appropriate read and write access to care records, and highlights the processes that are in place to protect the security of patient information.
|
|
There has been a great deal of confusion around the terms under which pharmacies, wholesalers, manufacturers and suppliers of systems to pharmacies may use and distribute the PIP Code. This statement intends to clarify the different licensing arrangements required by users of the PIP code.
|
|
The NPA has concerns regarding this proposal as the organisation is not convinced that the product can be used safely and effectively without the supervision of a health care professional.
|
|
Our comments refer to Figure 3; Vascular checks and the use made of pharmacists in this flow chart. The DH in Pharmacy in England Building on strengths- delivering the future April 2008 recognises the potential roles for community pharmacists in delivering the vascular risk assessments and includes pharmacies in the list of stakeholders with whom it will discuss delivery arrangements and support implementation, section 4.40.
|
|
The NPA is concerned that release of practice level data could release commercially sensitive data about a neighbouring pharmacy(ies). The NPA appreciates that the consultation document recognises that “drug prescription information…. can be considered as personal data” and that “prescribing data is confidential by virtue of the way it is collected”.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This is the response of the National Pharmacy Association (NPA) to the Department of Health’s (DH) ‘Arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances – and related services – to Primary Care’.
The NPA represents the owners of virtually all community pharmacies in the UK. We have, in voluntary membership, virtually all pharmacy owners. The overwhelming majority of our members contract with the NHS for the provision of NHS pharmaceutical services.
|
|
|
|
The CCA, AIMp, NPA, PSNC and RPSGB have today provided a joint response to the Department of Children, Schools and Families consultation on the Safeguarding Vulnerable Groups legislation and the proposed scheme that will be administered by the Independent Safeguarding Authority (ISA). A joint response was prepared because of the wide ranging implications of the legislation on the pharmacy profession and businesses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This response is written on behalf of the bodies that represent owners of community pharmacies, in response to the consultation on proposals for the content of the Responsible Pharmacist Regulations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
